Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5301
PUT
Exelixis
EXEL
$13B
| $1.99M | ﹤0.01% |
102,400
-30,800
| -23% | -$537K |
|
5302
PUT
Intellia Therapeutics
NTLA
$1.7B
| $1.99M | ﹤0.01% |
53,300
-4,100
| -7% | -$161K |
|
5303
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.6B
| $1.98M | ﹤0.01% |
+19,815
| New | +$1.98M |
|
5304
PUT
SK Telecom
SKM
$15.2B
| $1.98M | ﹤0.01% |
+96,700
| New | +$1.98M |
|
5305
CALL
Iovance Biotherapeutics
IOVA
$3.24B
| $1.98M | ﹤0.01% |
324,400
+152,200
| +88% | +$1.05M |
|
5306
PUT
Dine Brands
DIN
$445M
| $1.98M | ﹤0.01% |
29,300
-1,200
| -4% | -$88K |
|
|
DZSI
5307
DELISTED
DZS Inc. Common Stock
DZSI
| $1.98M | ﹤0.01% |
251,079
+112,177
| +81% | +$1.25M |
|
5308
VanEck Pharmaceutical ETF
PPH
$978M
| $1.98M | ﹤0.01% |
25,513
-4,808
| -16% | -$371K |
|
5309
CALL
Privia Health
PRVA
$2.76B
| $1.98M | ﹤0.01% |
71,700
-4,800
| -6% | -$127K |
|
5310
CALL
Warrior Met Coal
HCC
$5.23B
| $1.98M | ﹤0.01% |
53,900
+41,700
| +342% | +$1.54M |
|
|
SILV
5311
PUT
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $1.98M | ﹤0.01% |
277,100
+151,900
| +121% | +$930K |
|
5312
Fidelity MSCI Real Estate Index ETF
FREL
$1.48B
| $1.98M | ﹤0.01% |
79,421
-27,828
| -26% | -$718K |
|
5313
CALL
Ericsson
ERIC
$33.4B
| $1.98M | ﹤0.01% |
338,100
+100,600
| +42% | +$574K |
|
5314
CALL
Orion
OEC
$351M
| $1.98M | ﹤0.01% |
75,700
+33,400
| +79% | +$755K |
|
5315
PUT
Booz Allen Hamilton
BAH
$9.21B
| $1.97M | ﹤0.01% |
21,300
-38,500
| -64% | -$3.65M |
|
|
CGC
5316
CALL
Canopy Growth
CGC
$431M
| $1.97M | ﹤0.01% |
112,780
-53,840
| -32% | -$1.28M |
|
5317
CALL
Evercore
EVR
$11.7B
| $1.97M | ﹤0.01% |
17,100
+6,100
| +55% | +$758K |
|
5318
CALL
Direxion Daily FTSE China Bear 3X ETF
YANG
$98.8M
| $1.97M | ﹤0.01% |
10,565
-395
| -4% | -$75.1K |
|
5319
CALL
Plexus
PLXS
$7.31B
| $1.97M | ﹤0.01% |
20,200
+6,500
| +47% | +$652K |
|
5320
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.43B
| $1.97M | ﹤0.01% |
17,926
-78,814
| -81% | -$8.89M |
|
5321
CALL
USA Compression Partners
USAC
$3.84B
| $1.97M | ﹤0.01% |
93,100
-54,300
| -37% | -$1.12M |
|
5322
CALL
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.43B
| $1.97M | ﹤0.01% |
46,600
-13,200
| -22% | -$575K |
|
|
RWT
5323
Redwood Trust
RWT
$605M
| $1.97M | ﹤0.01% |
291,814
-91,666
| -24% | -$687K |
|
5324
Gorman-Rupp
GRC
$2.12B
| $1.97M | ﹤0.01% |
78,642
+1,213
| +2% | +$32.3K |
|
5325
PUT
Robert Half
RHI
$4.37B
| $1.97M | ﹤0.01% |
24,400
+11,400
| +88% | +$905K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.